ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin sheaths in ...
Dr. J. William Lindsey, Director of Multiple Sclerosis and Neuroimmunology at McGovern Medical School, UTHealth Houston, discusses how these social determinants of health impact the disease. (2:35) Is ...
Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...
Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects around 2.9 million people worldwide, and around 15,000 in Switzerland alone. One key feature ...
NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers ...
When an insurance denial blocks guest writer Denise Schnieders from getting an MS disease activity test, she decides to fight back.
Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects about 2.9 million people worldwide, and about 15,000 in Switzerland alone. One key feature of ...
Improved MRI scans of the myelin sheaths in the brain should allow multiple sclerosis to be detected at an early stage. Multiple sclerosis (MS) is a neurological disease that usually leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results